Health Canada drug identification number

DIN 02228947 — MIGRANAL NASAL SPRAY 4MG/ML 0.5 MG

MIGRANAL NASAL SPRAY 4MG/ML is a liquid of Dihydroergotamine marketed by STERIMAX INC. The full Dihydroergotamine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02228947
Brand name
MIGRANAL NASAL SPRAY 4MG/ML
Active ingredient
Dihydroergotamine
Strength
0.5 MG
Dosage form
LIQUID
Route
NASAL
Manufacturer
STERIMAX INC
Health Canada status
MARKETED
Drug class
Ergot alkaloid, 5-HT1 receptor agonist (migraine therapy)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Dihydroergotamine products

DINBrandStrengthFormManufacturerStatus
00027243 DIHYDROERGOTAMINE (DHE) 1 MG SOLUTION STERIMAX INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.